| 投资者关系活动类 | □特定对象调研 □分析师会议 | | --- | --- | | 别 | □媒体采访 √业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及人 | 线上参与南国置业 2025 年半年度业绩说明会的投资者 | | 员姓名 | | | 时间 | 2025 年 09 月 04 日（星期四）上午 10:00-11:00 | | 地点 | 上证路演中心 | | 上市公司接待人员 | 董事长、独立董事、总经理、董事会秘书、财务总监 | | 姓名 | | | | 1、问：请问李董事长，南置剥离地产业务后会转型做 | | | 物业轻资产方面吗？ | | | 答：尊敬的投资者，感谢您对公司的关注！公司及相关 | | | 机构正积极推进重大资产出售相关工作。已于 5 月 24 | | | 日、6 月 25 日、7 月 25 日、8 月 23 日分别披露《关于 | | 投资者关系活动主 | 筹划重大资产出售暨关联交易的进展公告》，有关公司 | | 要内容介绍 | 信息请以公司在指定信息披露媒体披露的公告为准。 | ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002305 证券简称：*ST南置 公告编号：2025-045号 南国置业股份有限公司 股票交易异常波动公告 南国置业股份有限公司(以下简称"公司")连续3个交易日（8月19日、8月20日、8月21日）收盘价格跌幅 偏离值累计超过12%，根据《深圳证券交易所交易规则》的相关规定，属于股票交易异常波动。 二、对重要问题的关注、核实情况说明 针对公司股票异常波动情况，公司董事会通过自查，并向公司控股股东、实际控制人进行了核实，现将 有关情况说明如下： 1、公司前期所披露的信息，不存在需要更正、补充之处； 2、公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息； 3、公司正在筹划重大资产出售暨关联交易事项。公司控股股东中国电建地产集团有限公司（以下简 称"电建地产"）拟受让公司持有的房地产开发业务等相关资产和负债。具体内容详见公司于2025年4月 25日披露的《关于筹划重大资产出售暨关联交易的提示性公告》及2025年5月24日、6月25日、7月25日 披露的《关于筹划重大资产出售暨关联交易的进展公告》； 本公司及董事会全体 ...

Group 1 - The company experienced abnormal stock trading fluctuations, with a cumulative closing price increase exceeding 12% over three consecutive trading days (August 12, 13, and 14) [1] - The board of directors conducted a self-examination and confirmed that there were no undisclosed significant matters affecting the stock price [2][3] - The company is planning a major asset sale and related party transaction, where its controlling shareholder intends to acquire its real estate development business and related assets and liabilities [2] Group 2 - The board confirmed that there are no undisclosed matters that should have been disclosed according to the Shenzhen Stock Exchange regulations [3] - The controlling shareholder and actual controller did not trade the company's stock during the period of abnormal trading fluctuations [2] - The company has been subject to "delisting risk warning" due to negative net assets and "other risk warning" due to uncertainty in its ability to continue as a going concern [5]

法律意见书 北京市中洲律师事务所 关于中交地产股份有限公司 法律意见书 致：中交地产股份有限公司 北京市中洲律师事务所（以下简称"本所"）受贵公司的委托，指 派本所执业律师陈思佳、霍晴雯出席了贵公司 2025 年第五次临时股东 大会。根据《中华人民共和国证券法》 （以下简称"证券法" ）、《中华人 民共和国公司法》 （以下简称"公司法" ）和中国证监会《上市公司股东 大会规则》 （以下简称"股东大会规则" ）等法律、法规和规范性文件以 、《证券法》和《股东大会规则》的要求，按 照律师行业公认的业务标准、道德规范和勤勉尽责精神，出具法律意见 如下： 及《中交地产股份有限公司章程》 （以下简称"章程" ）的规定，本律师 就本次股东大会的召集、召开程序、召开方式、出席会议人员及会议召 集人资格以及表决程序和表决结果的合法有效性出具本法律意见。 地址：北京市东城区建国门南大街 7 号荷华明城 D 座 6 层 邮编：100050 http://www.bjzhongzhou.com 电话：01051266607 传真：01058732091 -1- 为出具本法律意见书，本律师已对本次股东大会所涉及的有关事项 及文件资料 ...

Group 1 - The core opinion of the article is that the legal opinion issued by Beijing Deheng (Hangzhou) Law Firm confirms the legality and compliance of the major asset sale and related transactions of Sichuang Medical Technology Co., Ltd [1][4][14] - The transaction involves the transfer of 100% equity of Yihui Technology by Sichuang Medical to Shanhai Digital for a total price of 299.5995 million yuan [5][10] - The payment for the transaction will be made in cash, with the entire amount to be paid before the completion of the asset transfer [6][10] Group 2 - The legal opinion states that the transaction has received necessary approvals and authorizations from the company's board and shareholders [8][10][14] - The transfer of ownership for the assets has been completed, and the relevant registration procedures have been carried out [11][14] - There are no significant discrepancies between the actual situation of the transaction and the previously disclosed information [11][14] Group 3 - The company has confirmed that there have been no changes in the board of directors, supervisors, or senior management personnel of either the listed company or the target company since the disclosure of the restructuring report [12][14] - The transaction does not involve the transfer of debts and liabilities of the target company, and there have been no instances of fund occupation or guarantees provided to related parties during the transaction process [13][14] - All parties involved in the transaction are fulfilling their commitments and agreements as per the signed equity transfer agreement [13][14]

Core Viewpoint - The company, China Communications Real Estate Co., Ltd., has approved a revised draft of the major asset sale and related party transaction report during its supervisory board meeting, which is subject to shareholder approval [1][2][3] Group 1: Meeting Details - The fourth meeting of the tenth supervisory board was held on July 24, 2025, with all three supervisors present [1] - The meeting was chaired by Mr. Ye Chaofeng and complied with the relevant provisions of the Company Law and the company's articles of association [1] Group 2: Resolutions Passed - The supervisory board unanimously approved the revised draft of the major asset sale and related party transaction report, with a vote of 3 in favor, 0 against, and 0 abstentions [1][3] - The board also approved the audit report and review report related to the extended audit date of April 30, 2025, with the same voting results [3] - A resolution was passed to continue providing guarantees for certain target companies and their subsidiaries after the completion of the major asset sale, which will also require shareholder approval [3]

北京德恒（杭州）律师事务所 北京德恒（杭州）律师事务 所 关于思创医惠科技 股份有限公司 暨关联交易的补充法律意见（二） 北京德恒（杭州）律师事务所 关于思创医惠科技股份有限公司 重大资产出售暨关联交易的补充法律意见（二） 北京德恒（杭州）律师事务所 关于 思创医惠科技股份有限公司 重大资产出售暨关联交易的 补充法律意见（二） 关于 思创医惠科技股份有限公司 重大资产出售暨关联交易的 补充法律意见（二） 浙江省杭州市上城区新业路 200 号华峰国际商务大厦 10-11 楼 电话：0571-86508080 传真：0571-87357755 邮编：310020 德恒 12F20250065-5 号 致：思创医惠科技股份有限公司 北京德恒（杭州）律师事务所（以下简称"本所"）根据与思创医惠科技股 份有限公司（以下简称"公司" "上市公司"或"思创医惠"）签订的《专项法律 咨询合同》，担任上市公司重大资产重组（以下简称"本次交易"）的特聘专项法 律顾问。 就本次交易，本所已于 2025 年 4 月 28 日出具了《北京德恒（杭州）律师事 务所关于思创医惠科技股份有限公司重大资产出售暨关联交易的法律意见》（以 下简称 ...

证券代码：300078 证券简称：思创医惠 公告编号：2025-073 思创医惠科技股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或者重大遗漏。 一、监事会会议召开情况 思创医惠科技股份有限公司（以下简称"公司"）第六届监事会第八次会议 于 2025 年 7 月 14 日在温州市苍南县灵溪镇春晖路 433-505 号公投大楼会议室 以现场表决和通讯表决相结合的方式召开。会议通知于 2025 年 7 月 13 日通过电 子邮件、电话等方式送达各位监事，经全体监事一致同意，本次会议豁免通知期 限要求。本次会议应出席监事 3 人，实际出席监事 3 人。会议由监事会主席黄友 形先生召集并主持。本次会议的召集、召开和表决程序符合《中华人民共和国公 司法》（以下简称"《公司法》"）等法律法规和《公司章程》的规定。 二、监事会会议审议情况 报告书(草案)(二次修订稿)>及其摘要的议案》 公司拟向苍南县山海数字科技有限公司出售持有的医惠科技有限公司 年 2 月 28 日，公司根据《公司法》《中华人民共和国证券法》《上市公司重大 资产重组管理办法》等法律法规、规范性文件的相关 ...

Core Viewpoint - The company is planning to sell 90% of its stake in Shanghai Mining to Zhejiang Wolong Shenyu Investment Co., Ltd, which is a significant asset sale and constitutes a major asset restructuring according to relevant regulations [4][10][22]. Meeting Notice - The company emphasizes the importance of maintaining shareholder rights and ensuring orderly conduct during the shareholder meeting [1][2]. - Shareholders are required to bring identification and arrive on time for registration [1][2]. Meeting Agenda - The meeting is scheduled for June 30, 2025, at 1:00 PM in Shaoxing, Zhejiang Province [4]. - The agenda includes discussions on the major asset sale, compliance with regulations, and the independence of the evaluation agency [4][5][6]. Proposed Resolutions - The company proposes to transfer 90% of its stake in Shanghai Mining, with the transaction price set at approximately 191.11 million yuan after adjustments for cash dividends [7][8]. - The evaluation of the asset was conducted by Zhonglian Asset Appraisal Group, with the total value of 100% of Shanghai Mining assessed at 226.9 million yuan [7][18]. Compliance and Legal Framework - The transaction complies with the Company Law, Securities Law, and relevant asset restructuring regulations [6][30]. - The company has ensured that all necessary legal procedures have been followed, and the documentation is valid [30][31]. Financial Impact - The asset sale is expected to enhance the company's operational capabilities and focus on renewable energy business, resolving any competition issues with its controlling shareholder [20][21]. Shareholder Rights - Shareholders are reminded of their rights to speak, inquire, and vote during the meeting, while also being required to respect the meeting's order [2][3]. Evaluation and Independence - The evaluation agency's independence and the appropriateness of the evaluation methods have been confirmed, ensuring fair pricing for the transaction [16][31].

Core Viewpoint - The law firm Zhonglun has conducted a verification of the self-inspection report regarding stock trading activities related to Jiahua Food Co., Ltd. The report indicates that no relevant parties engaged in stock trading during the specified self-inspection period [1][6]. Group 1: Self-Inspection Results - The board of directors, supervisors, senior management, and their immediate family members did not engage in trading Jiahua Food's stock during the self-inspection period from October 24, 2024, to April 24, 2025 [3][4]. - The controlling shareholders, actual controllers, and their immediate family members also did not engage in trading Jiahua Food's stock during the self-inspection period [3][4]. - The trading counterparties and their immediate family members did not engage in trading Jiahua Food's stock during the self-inspection period [3][4]. - Individuals with insider information regarding the trading target and their immediate family members did not engage in trading Jiahua Food's stock during the self-inspection period [4][6]. - Service providers related to the transaction and their immediate family members did not engage in trading Jiahua Food's stock during the self-inspection period [4][6]. - Other individuals with knowledge of the major asset transaction did not engage in trading Jiahua Food's stock during the self-inspection period [6]. Group 2: Verification Opinion - The law firm confirms that all relevant parties within the scope of the self-inspection did not engage in trading Jiahua Food's stock during the specified period, based on the self-inspection reports and verification from the Shenzhen branch of China Securities Depository and Clearing Co., Ltd. [6][7].